The effects of darifenacin and tolterodine on heart rate (HR) in patients with overactive bladder (OAB)

Olshansky B1, Foote J2, Arguinzoniz M3, Lheritier K3, Quebe-Fehling E3, Steel M3 1. University of Iowa Hospitals, Iowa, IA, USA, 2. Midtown Urology and Surgical Center, Atlanta, GA, USA, 3. Novartis Pharma AG, Basel, Switzerland

Abstract Category

Detrusor Overactivity

Abstract 124
Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium
Scientific Podium Poster Session 14
Friday 1st December 2006
09:07 - 09:15